UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report: March 2, 2000
Medix Resources, Inc.
(Exact name of registrant as specified in its charter)
Colorado 0-24768 84-1123311
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
7100 E. Belleview Avenue, Englewood, CO 80111
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (303) 741-2045
None
(Former name or former address, if changes since last report)
Item 5. Other Events. Press release announcing
Changes in the Company's management team.
<PAGE>
Exhibits
Exhibit 99.1 Press release dated March 1, 2000 announcing changes in the
Company's management team.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDIX RESOURCES, INC.
Date: April 3, 2000 By: /s/ David Kinsella
David Kinsella
Secretary and Controller
R O B I N S C H O E N P U B L I C R E L A T I O N S
526 Penn Street Newtown, PA 18940 t: 215/504-2122 f: 215/504-2123
e-m: [email protected]
FOR IMMEDIATE RELEASE
March 1, 2000
MEDIX ANNOUNCES MANAGEMENT TEAM CHANGES
Denver, CO -- John Prufeta, CEO of Medix Resources, Inc. [OTC BB:MDIX], today
announced several changes to the Company's management team. Medix provides
Internet-based healthcare communication, data integration, and transaction
processing software through its Cymedix.com product line.
Effective March 1, 2000, John Prufeta, interim CEO, became permanent CEO and
assumed the additional title of president. David Pfeil, who has been functioning
as chief operating officer and chief technology officer of Medix, became
president and chief operating officer of Medix subsidiary Cymedix Lynx
Corporation. Pfeil also became a member of Medix's Board of Directors. John
Yeros resigned from the Board of Directors and as its Chairman. He also resigned
as president of Medix. Yeros will remain as a consultant to the company under a
two-year agreement. Additionally, the Board has appointed a committee of current
Board members to nominate a new chairman of the Board and the slate of
candidates for the upcoming annual meeting of shareholders.
"I'm extremely grateful to the Board to be given the opportunity to lead Medix
at this exciting juncture in its evolution," stated John Prufeta. "With the
recent sale of the balance of the staffing business, we are now focusing on an
aggressive agenda that will ensure our ability to compete successfully in the
iHealth software market."
"This is a terrific opportunity and I appreciate the Board's confidence in my
ability to contribute to Medix's efforts in the fast-moving iHealth
marketspace," stated David Pfeil. "I'm excited about bringing physicians
together with the various segments of the healthcare industry via the Internet."
"I'm honored to have served with the members of the Medix Board and the many
talented people who helped complete Medix's transition to an iHealth company,"
stated John Yeros. "We've made tremendous progress during the past year, the
future is bright, and the Company is in good hands."
Denver-based Medix Resources, through Cymedix Lynx Corporation, offers
Cymedix.com, a suite of fully-secure, patented Internet communications software
products, to the healthcare industry. Additional information about Medix
Resources and its products and services can be found by visiting its Web sites,
www.medixresources.com and www.cymedix.com, or by calling 800/326-8773.
* * *
"Safe Harbor" statement under the Private Securities Litigation Reform Act of
1995: The statements contained in this release, which are not historical facts,
contain forward-looking information with respect to plans, projections and/or
future performance of the Company, the occurrence of which involve certain risks
and uncertainties detailed in the Company's Form 10-KSB/A for 1998, which was
filed with the Securities and Exchange Commission on July 23, 1999, and its 1999
third quarter Form 10-QSB, which was filed with the Securities and Exchange
Commission on November 10, 1999. This information is available from the SEC or
the Company.
Contacts: General and Press Inquiries Investor Inquiries
----------------------------- -------------------
Robin Schoen Josh Golomb
Robin Schoen Public Relations SmallCaps Online Communications
215/504-2122 212/554-4158
